Literature DB >> 3331684

In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats.

M J Cunningham1, W N Choy, G T Arce, L B Rickard, D A Vlachos, L A Kinney, A M Sarrif.   

Abstract

Male B6C3F1 mice and Sprague-Dawley rats were exposed for 2 days, 6 h/day to 1,3-butadiene (BD) by inhalation (nose only) and their bone marrow cells were evaluated for the induction of micronuclei (MN) and sister chromatid exchanges (SCEs). A significant dose-dependent increase in MN induction was observed in mice. At 100 p.p.m., the frequency of micronucleated polychromatic erythrocytes was 6-fold above control with a maximal induction of 38-fold at 10,000 p.p.m. A significant increase in SCEs was also observed in mouse bone marrow cells starting at 100 p.p.m. with a 4-fold increase over the control evident at 10,000 p.p.m. The highest tested no observed effect level for both endpoints was 50 p.p.m. In contrast, rat bone marrow cells did not exhibit significant increases in micronucleated polychromatic erythrocytes or SCEs. These results indicate that BD is genotoxic in the bone marrow of the mouse but not the rat. This paralleled the chronic bioassays which showed mice to be more susceptible than rats to BD carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3331684

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  9 in total

Review 1.  The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study.

Authors:  J A Bond; M W Himmelstein; M A Medinsky
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

Review 3.  Biomonitoring of 1,3-butadiene and related compounds.

Authors:  S Osterman-Golkar; J A Bond
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 4.  Future directions--toxicology studies of 1,3-butadiene and isoprene.

Authors:  M G Bird
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

Review 5.  In vitro and in vivo genotoxicity of 1,3-butadiene and metabolites.

Authors:  G T Arce; D R Vincent; M J Cunningham; W N Choy; A M Sarrif
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

6.  Results of NTP-sponsored mouse cytogenetic studies on 1,3-butadiene, isoprene, and chloroprene.

Authors:  M D Shelby
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

7.  Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.

Authors:  U Wahnschaffe; A Bitsch; J Kielhorn; I Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-17

8.  1,3-Butadiene: linking metabolism, dosimetry, and mutation induction.

Authors:  J A Bond; G A Csanady; M L Gargas; F P Guengerich; T Leavens; M A Medinsky; L Recio
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

9.  hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant.

Authors:  J B Ward; M M Ammenheuser; W E Bechtold; E B Whorton; M S Legator
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.